PHYLLIS TETTEY-ENYO: Open Payments
NPI 1295189363 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 3 | $183 |
| SCPHARMACEUTICALS INC. | 1 | $132 |
| Astellas Pharma US Inc | 1 | $129 |
| Kowa Pharmaceuticals America, Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $94 |
| ABBVIE INC. | 1 | $30 |
| UCB, Inc. | 1 | $14 |
Products named: Dyanavel XR, FUROSCIX, Veozah, ZORYVE, INGREZZA, IMBRUVICA, Rystiggo.
Industry payments across GA — which companies pay providers there.
